Organ-on-chip Market Future Analysis, Overview, Growth Opportunities and Forecast till 2028

The Organ-on-chip Market report offers an in-depth assessment of market dynamics, the competitive landscape, segments, and regions in order to help readers to become familiar with the Organ-on-chip market. It particularly sheds light on market fluctuations, pricing structure, uncertainties, potential risks, and growth prospects to help players to plan effective strategies for gaining successful in the Organ-on-chip market. Importantly, it allows players to gain deep insights into the business development and market growth of leading companies operating in the Organ-on-chip market.

The global organ-on-chip market was valued at an estimated USD 25 million in 2020, and it is expected to reach USD 115 million by 2027, registering a CAGR of 30% over the forecast period.

Get a FREE Sample Copy of This Report:

https://www.marketinsightsreports.com/reports/02285850231/organ-on-chip-market-growth-trends-covid-19-impact-and-forecasts-2022-2027/inquiry?Mode=namita

Top Leading Companies of Organ-on-chip Market are - Altis Biosystems, AxoSim Inc., Bi/ond, BiomimX SRL, Elveflow, Emulate Inc., Hesperos, Hurel Corporation, Allevi, Inc., InSphero AG, MIMETAS B.V. and others.

Industry News and Updates:

In September 2019, Javelin Biotech and Pfizer entered a three-year development of a platform to evaluate absorption, distribution, metabolism, and excretion (ADME) properties of small molecules on an organ-on-a-chip platform. The platform will help inform human pharmacokinetic (PK) predictions, which are often crucial measurements evaluating new drug candidates in preclinical research. This has further increased the growth in the market studied.

In October 2019, the Biomedical Advanced Research and Development Authority (BARDA), a part of the US Department of Health and Human Services (HHS), announced its plans to provide technical expertise and approximately USD 13.5 million over the next two years to the Wake Forest Institute for Regenerative Medicine (WFIRM) of Winston-Salem, North Carolina, to validate how the group's lung-on-chip technology, also known as an organ tissue equivalent, works in modeling the effects of chlorine gas on human lungs.

Key Market Trends:

Lung-related Application is Expected to Exhibit the Good Growth Rate Over the Forecast Period

The recent global COVID-19 pandemic caused by the novel coronavirus, SARS-CoV-2, necessitates rapid advances in research and development activities for different approaches to treating the infection. For instance, in April 2020, researchers at the Wyss Institute demonstrated that human airway organ chips can be used to model COVID-19 and the immune response toward the same, in order to test the effectiveness of drugs to curb the infection. The development of new solutions to treat pulmonary diseases is currently of primary importance, as pulmonary diseases are found to be among the most dreadful conditions, globally.

North America Captured the Largest Market Share and is Expected to Retain its Dominance Over Forecast Period

The COVID-19 pandemic accelerated the use of Organ-on-Chip usage for the development and testing of drugs. The market has witnessed various collaborations between research institutes and market players. For instance, in October 2020, the United States Food and Drug Administration has entered into a collaborative agreement to use lung-chips from Emulate, Inc. to evaluate the safety of COVID-19 vaccines and protective immunity against SARS-CoV-2. Similarly, in October 2020, researchers at the U.S. Army Combat Capabilities Development Command (CCDC), Chemical Biological Center (CBC) has used Emulat's Lung on Chip technology for research on COVID-19.

Investigator Observers Strong Growth in Specific Regions:

- Europe Market (Germany, UK, France, Russia, Italy)

- Center East and Africa Market (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)

- South America Market (Brazil, Argentina, Colombia)

- North America Market (United States, Canada, Mexico)

- Asia Pacific Market (China, Japan, Korea, India, Southeast Asia).

The Latest Industry Data Included in this Report:
- Organ-on-chip Market Size & Analysis (2017 - 2027)
- Market Share Analysis of Organ-on-chip Market (%),2017 - 2027
- Organ-on-chip Market Share, By Brand
- Organ-on-chip Market Share, By Company
- Organ-on-chip Market Assessment & Opportunity (Value),2017 - 2027
- Major Companies Organ-on-chip Market Value Analysis & Forecast
- Promising Organ-on-chip Development by Major Companies
- Detailed Organ-on-chip Portfolio of the Major Companies
- Major Deals in the Organ-on-chip Market
- Major Companies Analysis

Browse Full Report at:

https://www.marketinsightsreports.com/reports/02285850231/organ-on-chip-market-growth-trends-covid-19-impact-and-forecasts-2022-2027?Mode=namita

We Offer Customization on Report Based on Specific Client Requirement:

- Country Level analysis for any 5 countries of your choice.

- Competitive analysis of any 5 key market players.

- 40 analyst hours to cover any other data point.

Contact Us:
Irfan Tamboli (Head of Sales) - Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.